Display options
Share it on

Saudi J Biol Sci. 2014 Jan;21(1):99-108. doi: 10.1016/j.sjbs.2013.08.002. Epub 2013 Aug 12.

Effect of melittin on mice stomach.

Saudi journal of biological sciences

Osama Abu-Zinadah, Tarek Rahmy, Abeer Alahmari, Faiza Abdu

Affiliations

  1. Department of Biological Science, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
  2. Department of Zoology, Faculty of Science, Suez Canal University, Ismailia, Egypt.
  3. Department of Biological Science, Faculty of Science, King Khalid University, Abha, Saudi Arabia.

PMID: 24596505 PMCID: PMC3937462 DOI: 10.1016/j.sjbs.2013.08.002

Abstract

Melittin, the main bee venom component, has many positive biological effects and a relatively low toxicity in various cell types. However, there is no evidence of the effect of melittin on gastrointestinal cells. In the present study, we investigated the histological and immuonohistochemical effects of melittin on mice stomach. Adult male mice (Albino Swiss) were randomly divided into two groups (7 mice for each group): control group and melittin only treated group (10 and 40 μg/kg). These mice were sacrificed, then samples from the stomach were collected and prepared for histopathological studies by using alcian blue stain and immuonohistochemical studies by using smooth muscle actin (SMA) antibody. Treatment with melittin alone do not cause any harmful effect on the stomach tissue where the microscopic examination of Alcian blue stained section showed the normal distribution of the mucous secreting cells of the stomach tissues. On other hand, no changes were observed on smooth muscle cells. This study demonstrated the safety of using melittin on gastrointestinal tissues if used in definite dose and for suitable duration, which offers an opportunity for its use as a treatment for many diseases of the gastrointestinal tract.

Keywords: Gastrointestinal tract; Melittin; SMA

References

  1. Biokhimiia. 1978 Aug;43(8):1452-7 - PubMed
  2. Biochem J. 1988 Jun 15;252(3):791-4 - PubMed
  3. Biochem Pharmacol. 2004 Mar 15;67(6):1047-56 - PubMed
  4. Prostaglandins Leukot Essent Fatty Acids. 2009 Nov-Dec;81(5-6):341-7 - PubMed
  5. Arch Biochem Biophys. 1990 Dec;283(2):249-57 - PubMed
  6. Pharm Res. 2002 Aug;19(8):1185-93 - PubMed
  7. J Membr Biol. 1985;87(1):35-44 - PubMed
  8. Biochim Biophys Acta. 1998 Mar 2;1369(2):346-54 - PubMed
  9. J Pharmacol Exp Ther. 2006 May;317(2):627-34 - PubMed
  10. Int Immunopharmacol. 2011 Dec;11(12):2062-72 - PubMed
  11. Pharmacol Ther. 2007 Aug;115(2):246-70 - PubMed
  12. FEBS Lett. 1974 Sep 15;46(1):141-4 - PubMed
  13. Am J Hum Genet. 2010 Dec 10;87(6):743-56 - PubMed
  14. Neurosci Lett. 2003 Feb 13;337(3):147-50 - PubMed
  15. Eur Biophys J. 2004 Nov;33(7):611-22 - PubMed
  16. Biochem Pharmacol. 2008 Mar 1;75(5):1104-14 - PubMed
  17. J Endocrinol. 1992 Feb;132(2):251-9 - PubMed
  18. Biochemistry. 1991 Jul 23;30(29):7171-80 - PubMed
  19. Biochem Biophys Res Commun. 2003 Jun 27;306(2):496-500 - PubMed
  20. Am J Med. 2003 Aug 18;115 Suppl 3A:15S-23S - PubMed
  21. Arch Biochem Biophys. 1989 Nov 15;275(1):263-70 - PubMed
  22. Biochemistry. 2008 Mar 4;47(9):2841-9 - PubMed
  23. Biochem Pharmacol. 2006 Apr 28;71(9):1289-98 - PubMed
  24. Pharm Res. 2007 Jul;24(7):1346-56 - PubMed
  25. Neuropeptides. 2007 Dec;41(6):465-75 - PubMed

Publication Types